Real-world evidence of first-line Osimertinib effectiveness in Bulgarian patients: a retrospective analysis

29/07/2025
29/07/2025
EU PAS number:
EUPAS1000000686
Study
Finalised
Study type

Study type

Non-interventional study
Non-interventional study

Non-interventional study design

Cohort
Study drug and medical condition

Medicinal product name

TAGRISSO

Study drug International non-proprietary name (INN) or common name

OSIMERTINIB